<p><b>NOTE:</b> (), % abundance by uds.</p><p>AZT, zidovudine; ABC, abacavir; 3TC, lamivudine; FTC, emtricitabine; DDI, didanosine.</p><p>Mutations in bold, IAS-USA major mutations in low abundance.</p><p>Mutation in <i>italic</i>, mutations detected by uds only.</p><p>TDF, tenofovir; D4T, stavudine; EFV, efavirenz; LPV, lopinavir; SQV, saquinavir; fAMP, fosamprenavir; NLF, nelfinavir; ATV, atazanavir; r, ritonavir boosting.</p
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
Initial HIV-1 therapy selection is informed by sequencing of a bulk PCR product to screen for antire...
At Week 96 of the Single-Tablet Regimen (STaR) study, more treatment-naïve subjects that received ri...
<p>HIV drug resistance mutations detected by standard Sanger sequencing (SS) and by Deep sequencing ...
CASTLE compared the efficacy of atazanavir/ritonavir with lopinavir/ritonavir, each in combination w...
International audienceSanger population sequencing (SPS) is the reference technique to monitor HIV-1...
CASTLE compared the efficacy of atazanavir/ritonavir with lopinavir/ritonavir, each in combination w...
<p>*Stanford HIVdb algorithm interpretation abbreviations: H – High level resistance; I – Intermedia...
International audienceUltra-deep sequencing (UDS) is a powerful tool for exploring the impact on vir...
Clinical relevance of low-frequency HIV-1 variants carrying drug resistance associated mutations (DR...
<p>Drug resistance interpretation of low-abundance and high-abundance mutations detected by ultra-de...
<p><i>Italic</i>: mutations only detected by UDS/Normal: mutations detected by both UDS and SS</p><p...
<p>(-): mutant clones less than 0.3% among total clones at each nucleotide sites.</p><p>LAM: lamivud...
Sequencing of a bulk polymerase chain reaction (PCR) product to identify drug resistance mutations i...
Detection of low-abundance drug resistance mutations (DRMs) of HIV-1 is an evolving approach in clin...
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
Initial HIV-1 therapy selection is informed by sequencing of a bulk PCR product to screen for antire...
At Week 96 of the Single-Tablet Regimen (STaR) study, more treatment-naïve subjects that received ri...
<p>HIV drug resistance mutations detected by standard Sanger sequencing (SS) and by Deep sequencing ...
CASTLE compared the efficacy of atazanavir/ritonavir with lopinavir/ritonavir, each in combination w...
International audienceSanger population sequencing (SPS) is the reference technique to monitor HIV-1...
CASTLE compared the efficacy of atazanavir/ritonavir with lopinavir/ritonavir, each in combination w...
<p>*Stanford HIVdb algorithm interpretation abbreviations: H – High level resistance; I – Intermedia...
International audienceUltra-deep sequencing (UDS) is a powerful tool for exploring the impact on vir...
Clinical relevance of low-frequency HIV-1 variants carrying drug resistance associated mutations (DR...
<p>Drug resistance interpretation of low-abundance and high-abundance mutations detected by ultra-de...
<p><i>Italic</i>: mutations only detected by UDS/Normal: mutations detected by both UDS and SS</p><p...
<p>(-): mutant clones less than 0.3% among total clones at each nucleotide sites.</p><p>LAM: lamivud...
Sequencing of a bulk polymerase chain reaction (PCR) product to identify drug resistance mutations i...
Detection of low-abundance drug resistance mutations (DRMs) of HIV-1 is an evolving approach in clin...
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
Initial HIV-1 therapy selection is informed by sequencing of a bulk PCR product to screen for antire...
At Week 96 of the Single-Tablet Regimen (STaR) study, more treatment-naïve subjects that received ri...